Logo image
Essential Role of Smooth Muscle STIM1 in Hypertension and Cardiovascular Dysfunction
Journal article   Open access   Peer reviewed

Essential Role of Smooth Muscle STIM1 in Hypertension and Cardiovascular Dysfunction

Modar Kassan, Karima Ait-Aissa, Eman Radwan, Vishal Mali, Samuel Haddox, Mohanad Gabani, Wei Zhang, Souad Belmadani, Kaikobad Irani, Mohamed Trebak, …
Arteriosclerosis, thrombosis, and vascular biology, Vol.36(9), pp.1900-1909
09/2016
DOI: 10.1161/ATVBAHA.116.307869
PMCID: PMC5061131
PMID: 27470514
url
https://doi.org/10.1161/ATVBAHA.116.307869View
Published (Version of record) Open Access

Abstract

Chronic hypertension is the most critical risk factor for cardiovascular disease, heart failure, and stroke. Here we show that wild-type mice infused with angiotensin II develop hypertension, cardiac hypertrophy, perivascular fibrosis, and endothelial dysfunction with enhanced stromal interaction molecule 1 (STIM1) expression in heart and vessels. All these pathologies were significantly blunted in mice lacking STIM1 specifically in smooth muscle (Stim1(SMC-/-)). Mechanistically, STIM1 upregulation during angiotensin II-induced hypertension was associated with enhanced endoplasmic reticulum stress, and smooth muscle STIM1 was required for endoplasmic reticulum stress-induced vascular dysfunction through transforming growth factor-β and nicotinamide adenine dinucleotide phosphate oxidase-dependent pathways. Accordingly, knockout mice for the endoplasmic reticulum stress proapoptotic transcriptional factor, CCAAT-enhancer-binding protein homologous protein (CHOP(-/-)), were resistant to hypertension-induced cardiovascular pathologies. Wild-type mice infused with angiotensin II, but not Stim1(SMC-/-) or CHOP(-/-) mice showed elevated vascular nicotinamide adenine dinucleotide phosphate oxidase activity and reduced phosphorylated endothelial nitric oxide synthase, cGMP, and nitrite levels. Thus, smooth muscle STIM1 plays a crucial role in the development of hypertension and associated cardiovascular pathologies and represents a promising target for cardiovascular therapy.
Angiotensin II Animals Blood Pressure - drug effects Cardiomegaly - genetics Cardiomegaly - metabolism Cardiomegaly - physiopathology Cardiomegaly - prevention & control Cyclic GMP - metabolism Disease Models, Animal Dose-Response Relationship, Drug Endoplasmic Reticulum Stress Fibrosis Genetic Predisposition to Disease Hypertension - genetics Hypertension - metabolism Hypertension - physiopathology Hypertension - prevention & control Male Mice, Knockout Muscle, Smooth, Vascular - drug effects Muscle, Smooth, Vascular - metabolism Muscle, Smooth, Vascular - pathology Muscle, Smooth, Vascular - physiopathology Myocardium - metabolism Myocardium - pathology NADPH Oxidases - metabolism Nitric Oxide Synthase Type III - metabolism Nitrites - metabolism Phenotype Phosphorylation Reactive Oxygen Species - metabolism Signal Transduction Stromal Interaction Molecule 1 - deficiency Stromal Interaction Molecule 1 - genetics Stromal Interaction Molecule 1 - metabolism Time Factors Transcription Factor CHOP - deficiency Transcription Factor CHOP - genetics Transforming Growth Factor beta - metabolism Vasodilation - drug effects Vasodilator Agents - pharmacology

Details

Logo image